DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

References

Goldstein S, Bates ER, Bhatt DL. , et al; AXIOM Investigators.
Phase 2 study of TAK-442, an oral factor Xa inhibitor, in patients following acute coronary syndrome.

Thromb Haemost 2014;
111 (06) 1141-1152

Download Bibliographical Data

Access:
Access:
Access: